We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.
Journal article
Br J Haematol
07/2018
182
200 - 211
down syndrome, neonatal leukaemia, transient abnormal myelopoiesis, transient leukaemia, transient myeloproliferative disorder, Antimetabolites, Antineoplastic, Blood Cell Count, Cell Transformation, Neoplastic, Critical Illness, Cytarabine, DNA Mutational Analysis, Down Syndrome, Exchange Transfusion, Whole Blood, Female, Fetal Diseases, GATA1 Transcription Factor, Humans, Leukapheresis, Leukemoid Reaction, Liver Diseases, Mutation, Neoplasm, Residual, Pregnancy, Prenatal Diagnosis, Prognosis, Recurrence, Risk Factors